The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer

N. C. Hait, D. Avni, A. Yamada, M. Nagahashi, T. Aoyagi, H. Aoki, C. I. Dumur, Z. Zelenko, E. J. Gallagher, D. Leroith, S. Milstien, K. Takabe, S. Spiegel

Research output: Contribution to journalArticlepeer-review

75 Scopus citations

Fingerprint

Dive into the research topics of 'The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences